Alkem Laboratories Ltd. announces a leadership change

Yes. The filing specifies that Nitin Agrawal resigned to pursue new professional opportunities; the accompanying resignation letter adds that these opportunities are aligned with his longer-term professional and personal growth. The resignation was tendered on 30 July 2026, and he will cease to hold the senior-management position on 30 September 2026. ^{[1] [2]}

The annexure’s generic “reason for change” field records only “Resignation”, while the main disclosure provides the fuller explanation. ^[3]

No interim CFO or search committee is announced in the regulatory disclosure. The only transition arrangement described is Agrawal’s commitment to support management and provide a seamless handover through 30 September 2026. ^[2] Accordingly, based on the 24 September filing, Alkem had not formally identified an interim CFO or disclosed a search committee before the effective departure date.

Nitin Agrawal’s CFO tenure was approximately two years, based on his reported joining of Alkem in 2024 and cessation of the CFO/senior-management role on 30 September 2026. The exact tenure in months cannot be established because the precise appointment date is not reported. His resignation was tendered on 30 July 2026, with the stated reason being pursuit of new professional opportunities. ^{[4] [1]}

There is no identified concurrent change in the Audit Committee or internal-audit function in the cited leadership disclosure. That filing records only the resignation of the CFO/KMP and does not mention any change in Audit Committee membership, the chairperson, the internal-audit head, or the internal-audit reporting structure. ^[1]

The recent Annual Report or Corporate Governance Report itself is not cited in the available material, so it is not possible to conclude that those governance or internal-control functions changed alongside the CFO transition. On the evidence available, the transition appears to be a standalone CFO departure rather than a documented broader governance reshuffle.

Nitin Agrawal’s tenure was approximately 2 years and 8 months, from 1 February 2024 to his effective cessation date of 30 September 2026. This is derived from the reported joining date ^[5] and the company’s Regulation 30 filing ^[1].

A like-for-like comparison with the average KMP tenure over the past five years cannot be calculated: the cited regulatory disclosure reports the resignation and cessation details but does not provide a five-year KMP tenure series or average tenure metric ^[3]. Therefore, it is not possible to conclude whether Agrawal’s tenure was above or below the KMP average.

On senior finance departures, the recent regulatory filing identifies only Agrawal’s CFO resignation. It does not name another CFO, finance director, or other senior finance executive as departing, nor does it disclose a successor in that filing ^[1]. Separately, the company disclosed the departure of CEO Vikas Gupta, effective 30 June 2026, but that was a CEO change rather than a finance leadership departure ^[6].